AzTrials
AzTrials

Covid19NCT04587245

The Provider Insurance Revenue Study in Healthcare Providers in the United States of America

An observational study of Covid19 and Financial Disclosure, run by ND Sciences, LLC at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators are enrolling 100 healthcare Provider volunteers (n=100) from across the United States to help to evaluate and document the financial impact of COVID-19 on Physicians and other healthcare Providers. Read more about this study

Who is it for?
Any age
Conditions the study is for
Covid19, Financial Disclosure
What is being tested?
Online questionnaire and interviews
How many people
100 participants
Where
1 siteUnited States
Study dates
1 Oct 2020to 15 Oct 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Child, Adult, Older adult

Study population: Healthcare Provider based anywhere in the United States who is eligible to submit claims to an insurance company on behalf of patients.

Who may be able to join

  • Healthcare Provider based anywhere in the United States who is eligible to submit claims to an insurance company on behalf of patients.
  • To agree to participate in this study

Who cannot join

  • Any condition that at the discretion of the principal investigator renders the subject ineligible to participate in this study.

Trial locations and contacts

1 site in 1 country.

Henry Broeska, PhD contact

949-332-9638

hbroeska0@saddleback.edu

Charles Bronson, MBA contact

415-530-8742

chasbronoson@gmail.com

United States1 site, 1 recruiting
  • University of California Irvine Beall Applied Innovation

    Irvine, California, 92617

    Henry Broeska, 949-332-9638, hbroeska0@saddleback.edu

    Charles Bronson, 415-530-8742, chasbronson@gmail.com

    Recruiting

Other trials in United States

About this study

Official title: The Provider Insurance Revenue Study

The investigators are enrolling 100 healthcare Provider volunteers (n=100) from across the United States to help to evaluate and document the financial impact of COVID-19 on Physicians and other healthcare Providers. This investigation will compare individual Physician revenues before and after the advent of the COVID-19 pandemic. The investigators expect to be able to differentiate between revenues lost due to the COVID-19-driven business recession and revenues lost due to the manipulation of reimbursement processes by insurance companies. The inextricable linkage between Payer and Physician revenues suggests that Payer revenues are higher at the direct expense of Physicians, since both streams come from the same sources of funding. The secondary objective is aimed at revealing the methods Payers use to retain more money.

Read the detailed description

Since the beginning of the COVID-19 pandemic in March, 2020, Physicians and other medical Providers have taken devastating hits to their practice revenues. Most of the losses are due to doctors being forced to curtail elective procedures and office visits as Americans were ordered to stay home during the height of the national health emergency.

As Physicians were able to return to work in the early Summer, even if only partially, many had to adjust to the newer medical practice of telehealth, and the lower revenues that came with it. The Centers for Medicare \& Medicaid Services (CMS) gave assurances to Physicians that Medicare would reimburse telehealth encounters at 100% of the office visit rate. But private Payers were under no such obligation. Across the country, Physicians are reporting that they're being reimbursed at about 70% of an office visit rate despite the fact that telehealth requires both resources and expertise to implement effectively, and each encounter takes up to twice as long as an office visit.

Adding to financial hardships, Physicians across the nation are reporting that legitimate insurance claims are being held up and denied by the insurance companies at a higher rate than ever, cutting off the cash that they need so desperately. As of June 1, only half of Physician practices say they have enough cash to stay open for another month.

In just 2 months in the spring of 2020, over 45 million Americans lost their jobs and for many, that also meant the loss of their employment-related health insurance. Despite shedding a massive number of members from their rolls, health insurance companies are actually predicting record profits for 2020. The pandemic it seems, is very good indeed for the health insurance business. Private investors and executives are taking huge dividends and bonuses out of the system just at a time when US healthcare needs a vast new investment of healthcare resources into the system. The good fortune of a few individuals and corporations comes at an as yet untold expense to American society.

The formula for insurance company success in a pandemic only happens one way. By keeping member premiums, delaying payments, and denying treatment authorizations, the large health insurance companies are taking advantage of the profound misfortunes of both doctors and patients during a national health emergency.

The COVID-19 pandemic will have adverse effects on the health of Americans that will be sprawling and long-felt. However, it is not for this study to decide whether private interests will always be antithetical to public interests when it comes to healthcare. That is a public debate that will continue to evolve as the profound weaknesses of the American way of distributing healthcare are magnified and exposed in a time of social upheaval.

The investigators do know that in order to get a handle on the major damage we see occurring in real-time- and to inform that debate, it is first necessary to measure it.

Being tested
Online questionnaire and interviews
Keywords
Healthcare providers, Covid19, Financial impact, Income
Medical subject headings
COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Online questionnaire and interviewsOther

    Online questionnaire, financial statements (one month per quarter in 2020) submitted electronically, interview with professional accounting firm and review of data and exit Interview

Study groups in NCT04587245
Study groupRoleWhat they receive
PhysiciansPhysician or healthcare Provider based anywhere in the United States who is eligible to submit claims to an insurance company on behalf of patients
Receives: Other: Online questionnaire and interviews

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in monthly income of healthcare Providers from baseline to 6, 9 and 12 months after the beginning of the COVID-related events

    Change in monthly income of healthcare Providers from baseline to 6, 9 and 12 months after the beginning of the COVID-related events

    Measured: 12 months

Secondary outcomes (1)
  1. Differences in Accounts Receivable (AR) due to claim denials over 4 quarters: Differences in recoveries of AR.

    Differences in Accounts Receivable (AR) due to claim denials over 4 quarters: Differences in recoveries of AR.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Oct 2020
  2. Study start1 Oct 2020
  3. Primary completion15 Oct 2022 (estimated)
  4. Study completion15 Oct 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04587245
Sponsor's protocol ID
PIRStudy
Status last verified
Oct 2021
First submitted
7 Oct 2020
Last updated
18 Oct 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Covid19 and Financial Disclosure, run by ND Sciences, LLC at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Henry Broeska, PhD (949-332-9638, hbroeska0@saddleback.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in monthly income of healthcare Providers from baseline to 6, 9 and 12 months after the beginning of the COVID-related events (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in